| Joseph Eugene West, MD | |
|
1240 Jesse Jewell Pkwy Se, Suite 500, Gainesville, GA 30501-3862 | |
| (770) 536-9864 | |
| (770) 297-5023 |
| Full Name | Joseph Eugene West |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 25 Years |
| Location | 1240 Jesse Jewell Pkwy Se, Gainesville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043375025 | NPI | - | NPPES |
| 398169319A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 55904 (Georgia) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 055904 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Halcyon Hospice | Cumming, GA | Hospice |
| Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Georgia Diagnostic Associates And Clinic, Llc | 1951655737 | 71 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
| Entity Name | Northeast Georgia Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891745212 PECOS PAC ID: 6901898386 Enrollment ID: O20040402001277 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
| Entity Name | Northeast Georgia Diagnostic Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215976634 PECOS PAC ID: 5092700377 Enrollment ID: O20040416000499 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
| Entity Name | Gwinnett Physician Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578574661 PECOS PAC ID: 9133211139 Enrollment ID: O20070822001035 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
| Entity Name | Northeast Georgia Diagnostic Associates And Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144719311 PECOS PAC ID: 1951655737 Enrollment ID: O20181114000949 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Eugene West, MD 1240 Jesse Jewell Pkwy Se, Suite 500, Gainesville, GA 30501-3862 Ph: (770) 536-9864 | Joseph Eugene West, MD 1240 Jesse Jewell Pkwy Se, Suite 500, Gainesville, GA 30501-3862 Ph: (770) 536-9864 |
News Archive
Scientists at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have identified a gene that may provide a new starting point for developing treatments for Alzheimer's disease (AD).
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
"Almost two years after Cyclone Nargis killed nearly 140,000 people in Myanmar, the repression of rights in areas hit by the cyclone continues and the humanitarian space in the country is shrinking instead of growing as originally hoped, a [Human Rights Watch] report released on Thursday said," Reuters AlertNet reports.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
› Verified 9 days ago
James D Jackson, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1285 Sims St, Gainesville, GA 30501 Phone: 770-219-8583 | |
Eileen Javellana, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 725 Jesse Jewell Pkwy Se, Gainesville, GA 30501 Phone: 678-207-4373 Fax: 770-533-4727 | |
Dr. Nitya S Chandra, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501 Phone: 770-534-2020 Fax: 770-534-8025 | |
Dr. Lisa Armsrees Gillespie, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-8420 | |
Dr. Noelle Claudine Stanley, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1211 Sherwood Park Dr Ne Ste B, Gainesville, GA 30501 Phone: 770-219-9179 | |
Kedric Naylor, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 Fax: 770-538-7872 | |
Dr. William Nathan Blake, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Ngpg Inpatient Medicine, Gainesville, GA 30501 Phone: 770-219-6000 Fax: 770-219-6021 |